Kevin J. Yeaman - 10 Jun 2025 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Issuer symbol
DLB
Transactions as of
10 Jun 2025
Net transactions value
-$869,060
Form type
4
Filing time
12 Jun 2025, 20:35:59 UTC
Previous filing
28 Feb 2025
Next filing
26 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
YEAMAN KEVIN J President and CEO, Director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO /s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman 12 Jun 2025 0001200469

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $1,137,500 +25,000 +22% $45.50 139,725 10 Jun 2025 By a trust F1
transaction DLB Class A Common Stock Options Exercise $560,922 +8,683 +6.2% $64.60 148,408 10 Jun 2025 By a trust F1
transaction DLB Class A Common Stock Sale $2,553,775 -33,504 -23% $76.22 114,904 10 Jun 2025 By a trust F1, F2
transaction DLB Class A Common Stock Sale $13,706 -179 -0.16% $76.57 114,725 10 Jun 2025 By a trust F1
holding DLB Class A Common Stock 127,735 10 Jun 2025 Direct F3
holding DLB Class A Common Stock 3 10 Jun 2025 By a son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -25,000 -13% $0.000000 160,615 10 Jun 2025 Class A Common Stock 25,000 $45.50 By a trust F1, F4
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -8,683 -14% $0.000000 52,817 10 Jun 2025 Class A Common Stock 8,683 $64.60 By a trust F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
F2 The shares were sold in multiple transactions at prices ranging from $75.555 to $76.50, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F4 This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
F5 This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares.